Efendic S, Karlander S, Vranic M
Department of Endocrinology, Karolinska Hospital, Stockholm, Sweden.
J Clin Invest. 1988 Jun;81(6):1953-61. doi: 10.1172/JCI113543.
Glucose cycling (GC; G in equilibrium G6P) equals 14% of glucose production in postabsorptive man. Our aim was to determine glucose cycling in six lean and six overweight mild type II diabetics (fasting glycemia: 139 +/- 10 and 152 +/- 7 mg/dl), in postabsorptive state (PA) and during glucose infusion (2 mg/kg per min). 14 control subjects were weight and age matched. GC is a function of the enzyme that catalyzes the reaction opposite the net flux and is the difference between hepatic total glucose output (HTGO) (2-[3H]glucose) and hepatic glucose production (HGP) (6-[3H]-glucose). Postabsorptively, GC is a function of glucokinase. With glucose infusion the flux is reversed (net glucose uptake), and GC is a function of glucose 6-phosphatase. In PA, GC was increased by 100% in lean (from 0.25 +/- 0.07 to 0.43 +/- .08 mg/kg per min) and obese (from 0.22 +/- 0.05 to 0.50 +/- 0.07) diabetics. HGP and HTGO increased in lean and obese diabetics by 41 and 33%. Glucose infusion suppressed apparent phosphatase activity and gluconeogenesis much less in diabetics than controls, resulting in marked enhancement (400%) in HTGO and HGP, GC remained increased by 100%. Although the absolute responses of C-peptide and insulin were comparable to those of control subjects, they were inappropriate for hyperglycemia. Peripheral insulin resistance relates to decreased metabolic glucose clearance (MCR) and inadequate increase of uptake during glucose infusion. We conclude that increases in HGP and HTGO and a decrease of MCR are characteristic features of mild type II diabetes and are more pronounced during glucose infusion. There is also an increase in hepatic GC, a stopgap that controls changes from glucose production to uptake. Postabsorptively, this limits the increase of HGP and glycemia. In contrast, during glucose infusion, increased GC decreases hepatic glucose uptake and thus contributes to hyperglycemia. Obesity per se did not affect GC. An increase in glucose cycling and turnover indicate hepatic insulin resistance that is observed in addition to peripheral resistance. It is hypothesized that in pathogenesis of type II diabetes, augmented activity of glucose-6-phosphatase and kinase may be of importance.
糖循环(GC;葡萄糖与葡萄糖-6-磷酸处于平衡状态)占空腹状态下人体葡萄糖生成量的14%。我们的目的是测定6名体重正常的人和6名超重的轻度II型糖尿病患者(空腹血糖:139±10和152±7mg/dl)在空腹状态(PA)以及葡萄糖输注期间(2mg/kg每分钟)的糖循环情况。选取了14名年龄和体重匹配的对照者。GC是催化与净通量相反反应的酶的一种功能,等于肝脏总葡萄糖输出量(HTGO)(2-[3H]葡萄糖)与肝脏葡萄糖生成量(HGP)(6-[3H]葡萄糖)的差值。在空腹状态下,GC是葡萄糖激酶的一种功能。随着葡萄糖的输注,通量发生逆转(净葡萄糖摄取),此时GC是葡萄糖-6-磷酸酶的一种功能。在空腹状态下,体重正常的糖尿病患者(从0.25±0.07增至0.43±0.08mg/kg每分钟)和肥胖糖尿病患者(从0.22±0.05增至0.50±0.07)的GC增加了100%。体重正常和肥胖的糖尿病患者的HGP和HTGO分别增加了41%和33%。与对照者相比,葡萄糖输注对糖尿病患者表观磷酸酶活性和糖异生的抑制作用要小得多,导致HTGO和HGP显著增强(400%),GC仍增加了100%。尽管C肽和胰岛素的绝对反应与对照者相当,但对于高血糖来说并不适当。外周胰岛素抵抗与代谢性葡萄糖清除率(MCR)降低以及葡萄糖输注期间摄取增加不足有关。我们得出结论,HGP和HTGO增加以及MCR降低是轻度II型糖尿病的特征性表现,在葡萄糖输注期间更为明显。肝脏GC也会增加,这是一种从葡萄糖生成向摄取转变的控制机制。在空腹状态下,这会限制HGP和血糖的升高。相反,在葡萄糖输注期间,GC增加会降低肝脏葡萄糖摄取,从而导致高血糖。肥胖本身并不影响GC。糖循环和周转增加表明除了外周抵抗外还存在肝脏胰岛素抵抗。据推测,在II型糖尿病的发病机制中,葡萄糖-6-磷酸酶和激酶活性增强可能具有重要意义。